Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Maxcyte, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +7 vs. Q1 2022
- Shares held
- 68.3M
- −185.8K (−0.3%) vs. Q1 2022
- Total value
- $322.7M
- −$156.1M (−32.6%) vs. Q1 2022
- New holders
- 22
- 38 more added
- Sold out
- 15
- 30 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MXCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $78.0M |
| Q1 2026 | 132 | $46.2M |
| Q4 2025 | 112 | $98.0M |
| Q3 2025 | 112 | $110.8M |
| Q2 2025 | 120 | $155.5M |
| Q1 2025 | 115 | $193.8M |
| Q4 2024 | 119 | $301.9M |
| Q3 2024 | 120 | $267.4M |
| Q2 2024 | 114 | $268.0M |
| Q1 2024 | 124 | $280.8M |
| Q4 2023 | 121 | $316.1M |
| Q3 2023 | 120 | $200.8M |
| Q2 2023 | 116 | $303.3M |
| Q1 2023 | 115 | $327.9M |
| Q4 2022 | 105 | $377.7M |
| Q3 2022 | 109 | $453.8M |
| Q2 2022 | 104 | $322.7M |
| Q1 2022 | 99 | $479.8M |
| Q4 2021 | 104 | $683.6M |
| Q3 2021 | 81 | $665.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Maxcyte, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3,395,510 | $16.1M | 0.00% | +110,914+3.4% | Added |
| Vitruvian Partners LLP | 5,043,356 | $23.9M | 4.05% | +657,686+15.0% | Added |
| BlackRock Inc. | 5,663,419 | $26.8M | 0.00% | +219,582+4.0% | Added |
| Casdin Capital, LLC | 13,971,334 | $66.1M | 5.59% | 00.0% | Unchanged |
| D1 Capital Partners L.P.SuperinvestorD1 Capital Partners | 0 | $0 | 0.00% | −3,510,000−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −776,963−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −151,706−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −137,958−100.0% | Sold out |
| Cna Financial Corp | 0 | $0 | 0.00% | −47,974−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −46,942−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −45,109−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −37,018−100.0% | Sold out |
| Must Asset Management Inc. | 0 | $0 | 0.00% | −27,027−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −13,753−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −13,143−100.0% | Sold out |
| Nkcfo LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,261−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −32,025−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |